G
Market Data
$6.52+$0.57 (+9.58%)
GYRE · Last trade
Prev Close
$5.95
Range (29d)
$5.82 – $7.34
Recent Filings
- 8-K172.9 KBGYRE THERAPEUTICS, INC.Jun 16, 6:30 AM ET·0001140361-26-025324
- 8-K8.9 MBGYRE THERAPEUTICS, INC.Jun 2, 6:09 AM ET·0001140361-26-023625
- 8-K4.6 MBGYRE THERAPEUTICS, INC.May 14, 5:25 PM ET·0001140361-26-021360
- 8-K185.2 KBGYRE THERAPEUTICS, INC.May 12, 5:03 PM ET·0001140361-26-020845
- 10-Q13.5 MBGYRE THERAPEUTICS, INC.May 8, 4:16 PM ET·0001193125-26-214676
- 8-K559.9 KBGYRE THERAPEUTICS, INC.May 6, 8:30 PM ET·0001193125-26-209789
- 8-K580.3 KBGYRE THERAPEUTICS, INC.May 4, 9:12 AM ET·0001140361-26-018716
- 8-K/A173.6 KBGYRE THERAPEUTICS, INC.Apr 17, 8:55 AM ET·0001140361-26-015307
- 8-K157.8 KBGYRE THERAPEUTICS, INC.Mar 23, 7:51 AM ET·0001140361-26-010654
- 10-K23.7 MBGYRE THERAPEUTICS, INC.Mar 13, 4:31 PM ET·0001193125-26-106251
Insiders
10- BARRETT M JAMESDirector, 10% Owner
- BARRIS PETER J10% Owner
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- BLIXT CHARLES ADirector
- BROWN JULIA RDirector
- BURRILL STEVENDirector
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- Bencherif MerouaneVP, Preclinical Research
- Bergmann Joshua BenjaminGC and Corporate Secretary
Tickers
Addresses
business
12730 HIGH BLUFF DRIVE SUITE 250
SAN DIEGO, CA, 92130
mailing
12730 HIGH BLUFF DRIVE SUITE 250
SAN DIEGO, CA, 92130
Former Names
- CATALYST BIOSCIENCES, INC.2023-10-27
- TARGACEPT INC2015-08-19